Elsevier,
Principles of Gender-Specific Medicine (Fourth Edition)
Sex and Gender-Specific Biology in the Postgenomic Era
2023, Pages 409-429
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reduced Inequalities by emphasizing the importance of gender-specific medicine in pharmaceutical development and global healthcare, aiming to improve health outcomes for all genders. By addressing the challenges faced by the pharmaceutical industry in integrating knowledge on sex-specific biological differences into drug development programs, the chapter advocates for strategies to promote equity in healthcare access and outcomes. Additionally, it recognizes the importance of addressing gender disparities in healthcare and advocating for approaches that ensure equal access to gender-specific pharmaceuticals. Through these efforts, the content supports the goal of reducing inequalities in healthcare access and outcomes, ultimately contributing to the promotion of good health and well-being for all individuals, regardless of gender.
The study shows that resource variables are relevant for understanding the situation of cancer patients. Clinicians who notice low levels of sense of coherence, resilience, or optimisms in their patients will be better prepared for identifying patients in need for interventions. Especially younger patients deserve special attention.
Register today for the ninth RELX SDG Inspiration Day - a free, online event for thought leaders, corporate representatives, students, investors, government and NGOs to explore issues, gain practical insights and be inspired to take action in support of the UN Sustainable Development Goals.
The current review seeks to provide a concise overview of the neuropathology and genetics underlying Alzheimer’s disease, and then summarize the most promising clinically available and experimental biomarkers of AD.
The New Public Health (Fourth Edition), 2023, Pages 1097-1158
This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities. It examines the globalization of health as there is increase focus on the international transfer of diseases and the imperative of cooperating to combat inequity under societal conditions that create the spread of diseases and their effects on individual nations and the global community.
This Article supports SDG 3 by providing the first comprehensive review of the global burden of hepatis B and C in people with tuberculosis, through a systematic review and meta-analysis including 127 studies. The review found a high prevalence of these infections in this patient population, showing the need for routine hepatitis testing at the point of diagnosis of tuberculosis.
This Article supports SDG 3 by analysing several cohorts of people with HIV/HCV co-infection across 6 high-income countries, and identifying that a substantial proportion had not commenced direct-acting antiviral treatment for HCV infection despite unrestricted access. Factors associated with commencement or lack thereof are explored; for example, people with indicators of low engagement with HIV care (eg, not on antiretroviral therapy) were more likely not to have commenced HCV direct-acting antiviral treatment)
This study was designed to explore the relationship between Alzheimer's disease (AD) rates and socioeconomic conditions in 120 countries.
Elsevier,
Nutrition Science, Marketing Nutrition, Health Claims, and Public Policy, 2023, pp 297-305
This chapter aligns with Goal 3: Good Health and Wellbeing and Goal 12: Responsible Consumption by making public policymakers and nutrition marketers aware of how food and nourishment are linked to environmental conditions, as well as how sustainable approaches in nutrition marketing enhance positive behavior and build healthy societies.
Drinking water and sanitation services in high-income countries typically bring widespread health and other benefits to their populations.
